Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Palbociclib | 19.9526 | uM | 4 | 2500.00 | 1726.92 | 1446.00 | 3011.25 | 0.4802 | -0.1985 |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 4 | 2500.00 | 1726.92 | 2569.00 | 3011.25 | 0.8531 | 0.6407 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 2805.00 | 3011.25 | 0.9315 | 0.8307 | |
| SK-BR-3 | Taxol | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 1449.00 | 3011.25 | 0.4812 | -0.1965 |
| SK-BR-3 | Palbociclib | 0.01 | uM | 4 | 2500.00 | 1726.92 | 2514.00 | 3011.25 | 0.8349 | 0.5971 |
| SK-BR-3 | Taxol | 1 | uM | 4 | 2500.00 | 1726.92 | 977.00 | 3011.25 | 0.3245 | -0.5084 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 4 | 2500.00 | 1726.92 | 2066.00 | 3011.25 | 0.6861 | 0.2504 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 2908.00 | 3011.25 | 0.9657 | 0.9149 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3503.00 | 3011.25 | 1.1633 | 1.4150 | |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 4 | 2500.00 | 1726.92 | 2634.00 | 3011.25 | 0.8747 | 0.6926 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 3106.00 | 3011.25 | 1.0315 | 1.0788 |
| SK-BR-3 | Methotrexate | 1 | uM | 4 | 2500.00 | 1726.92 | 1818.00 | 3011.25 | 0.6037 | 0.0662 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 4 | 2500.00 | 1726.92 | 1146.00 | 3011.25 | 0.3806 | -0.4002 |
| SK-BR-3 | Taxol | 0.001 | uM | 4 | 2500.00 | 1726.92 | 3340.00 | 3011.25 | 1.1092 | 1.2758 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 1045.00 | 3011.25 | 0.3470 | -0.4654 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 4 | 2500.00 | 1726.92 | 1172.00 | 3011.25 | 0.3892 | -0.3832 |
| SK-BR-3 | Methotrexate | 10 | uM | 4 | 2500.00 | 1726.92 | 1791.00 | 3011.25 | 0.5948 | 0.0465 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 4 | 2500.00 | 1726.92 | 1556.00 | 3011.25 | 0.5167 | -0.1218 |
| SK-BR-3 | Omipalisib | 3.1623 | uM | 4 | 2500.00 | 1726.92 | 828.00 | 3011.25 | 0.2750 | -0.6000 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 2892.00 | 3011.25 | 0.9604 | 0.9018 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 2810.00 | 3011.25 | 0.9332 | 0.8348 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5122.00 | 4892.25 | 1.0470 | 1.1605 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5078.00 | 4892.25 | 1.0380 | 1.1294 | |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 4 | 5000.00 | 3240.08 | 4768.00 | 4892.25 | 0.9746 | 0.9153 |
| SK-BR-3 | Omipalisib | 1 | uM | 4 | 5000.00 | 3240.08 | 1606.00 | 4892.25 | 0.3283 | -0.6929 |